Alzheimer patients
Andhra Pradesh ~ India ~ International ~ City ~ Entertainment ~ Business ~ Sports ~ Technology ~ Health ~ Features
Breast Cancer ~ Swine Flu ~ Lung Cancer ~ Heart attack ~ Pregnancy ~ All Health Topics
Home / Health News / 2009 / July 2009 / July 13, 2009
Alzheimers patients may not benefit from eating brain food fish
RSS / Print / Comments


Walking at least 6 miles per week 'can reduce Alzheimer's risk'

Soon, drug to stop memory loss

Low testosterone levels could lead to Alzheimer's

More on Dementia

Alzheimer's Disease

Working memory functions despite brain damage

New gene could explain relationship between diabetes, Alzheimer's

Bilingualism boosts brain prowess

More on Alzheimer's Disease

Health News

Waist size, not BMI can foretell cardiovascular risk in children
A new study by researchers at the University of Georgia, the Menzies Research Institute in Hobart, Australia and the Murdoch Childrens Research Institute in Melbourne, Australia has found that waist circumference is a better indicator of a childs risk for cardiovascular disease and diabetes later in life, as compared to BMI. ANI

Internal body temperature regulates body clock
Fluctuations in internal body temperature regulate the bodys circadian rhythm, the 24-hour cycle that controls metabolism, sleep and other bodily functions, revealed UT Southwestern Medical Center researchers. ANI

Egyptian mummies discovery indicates 'cancer is man-made'
A study of ancient remains has found that cancer is a man-made disease fuelled by pollution and changes to diet and lifestyle. ANI

Alzheimers patients may not benefit from eating brain food fish

People with Alzheimers disease may not benefit from eating fish, even though it is considered to be a brain food, say American researchers.

London, July 13 : People with Alzheimer's disease may not benefit from eating fish, even though it is considered to be a "brain food", say American researchers.

Two pieces of research have shown that the chances of getting the disease may be reduced, or its progression prevented, by consuming a fish-based diet, but further work is needed.

Two studies were carried out to determine the effects of DHA, an omega-3 fatty acid found in oily fish.

While studies conducted in the past have suggested that fish oil rich in omega-3 can protect the brain from age-related dementia, the new research has cast doubt on the claims.

Funded by the Alzheimer's Disease Co-operative Study (ADCS), the first trial lasted 18 months, during which it compared the effects of DHA and a dummy placebo on 402 volunteers with an average age of 76 who had been diagnosed with mild to moderate Alzheimer's.

The researchers associated with the trial say that, at the end of the study, there was nothing to conclusively show that omega-3 supplements improved participants' memory and mental performance scores.

The second trial ran for six months, during which a DHA manufacturer tested one of its products on a group of 485 healthy people.

It did show some improvement in one test of memory and learning. However, those participating in the trial did not have Alzheimer's disease or any other form of dementia.

The findings of both trials were presented at the International Conference on Alzheimer's Disease (ICAD) in Vienna.

"These trial results do not support the routine use of DHA for patients with Alzheimer's," the Scotsman quoted Dr. Joseph Quinn, from Oregon Health and Sciences University, who led the ADCS study, as saying.

However, the researchers presenting the findings did say that there was some evidence that DHA might help people with a particular genetic make-up.

"These studies show that using omega-3 fatty acids as a treatment late on may not be effective against Alzheimer's," Dr Simon Ridley, research manager at the Alzheimer's Research Trust, said.

"But with previous population studies suggesting that fish oils could reduce dementia risk, getting oily fish, such as mackerel, herring, salmon and sardines into our weekly menus could still be good advice.

"This shouldn't spell the end of research into omega-3, however. It could be that omega-3 given very early in the disease process could make a difference, but for that to happen we must drive forward studies that improve our methods of diagnosing Alzheimer's disease," he added.

Dr William Thies, chief medical and scientific officer at the Alzheimer's Association, said: "These two studies - and other recent Alzheimer's therapy trials - raise the possibility that treatments for Alzheimer's must be given very early in the disease for them to be truly effective. For that to happen, we need to get much better at early detection of Alzheimer's."


Link to this page

Suggested pages for your additional reading on Facebook

© 2000-2017 All Rights Reserved and are of their respective owners.
Disclaimer, Terms of Service & Privacy Policy | Contact Us